Neogenomics Laboratories

NeoGenomics News

Looking for NeoAccess? Go here to log in

3/27/2024

NeoGenomics at COA

NeoGenomics will be exhibiting at the 2024 Community Oncology Conference taking place in Orlando April 4-5. Stop by Booth #226 and meet the team.

Test Updates

 IHC

OCT2 IHC Clone Change

Beginning with samples processed Tuesday March 26th, the OCT2 IHC test now uses the MRQ-2 clone instead of the PT2 clone. This is due to a vendor issue with clone PT2. The newly established MRQ-2 clone was validated in accordance to CAP regulations.

  • The PT2 clone will continue to be listed on the OCT2 External QC Report as we work to update that information within the reporting system
  • No changes to level of service, CPT Codes, or TAT
 

Molecular

Molecular Specimen Hold Services – Effective Monday April 15th, the following updates will be implemented.

  • Discontinuation:
    • Freeze & Hold option will be discontinued. Please select one of the Extract & Hold options listed below as a replacement.
  • Expansion:
    • Extract & Hold option will be available as follows. Options can be ordered individually or concurrently, if desired
      • Extract & Hold – DNA: DNA will be isolated from viable cells and stored in freezer. Select this option if possible test to be ordered is DNA-based. Examples: FLT3 Mutation Analysis, IDH1/IDH2 Mutation Analysis by PCR
      • Extract & Hold – RNA: RNA will be isolated from viable cells and stored in freezer. Select this option if possible test to be ordered is RNA-based. Examples: IgVH Mutation Analysis, PML-RARA Translocation t(15;17)
      • Extract & Hold – TNA: Total nucleic acid (TNA), i.e. both DNA and RNA, will be isolated from viable cells and stored in freezer. Select this option if possible test to be ordered is TNA-based. Examples: NGS assays, such as Neo Comprehensive and NeoTYPE profiles.
    • Analysis is not performed until testing is ordered. Processed samples are retained for 28 days.
    • Charges will be waived when testing is ordered on held specimens. Otherwise, a fee will be billed to client for each extraction option that is ordered. For pricing information, please contact your local NeoGenomics sales rep or Client Services at 866.776.5907, option 3.
  • Coming Soon: Test webpage to list all tests available for each aforementioned Extract & Hold option to assist with the ordering of the service.

 

Requisition Updates

New versions of the IHC and Breast Cancer test requisitions, aligning with recent new product launches and test updates, are available for download on our website. For paper copy orders, please contact our Client Services team.

  • Immunohistochemistry and Special Stains- version 031224
  • Breast Cancer- version 031924
 

Test Discontinuations

Molecular

KRAS G12C Sponsored Testing Program - Effective Sunday, March 31st, The KRAS G12C Sponsored Testing Program (KRAS STP), offering no cost testing to help identify KRAS G12C mutation in patients with advanced non-small cell lung cancer (NSCLC), will be discontinued.

  • Orders received and accessioned between now and March 30 will process through the KRAS STP as normal.
  • Orders received and accessioned on March 31 and beyond will be put on hold while our Client Services team reaches out to inform on alternative testing options.

For any questions on the discontinuation of this program or for more information on alternative suggestions, please contact your local NeoGenomics Sales Consultant or our Client Services team at (866) 776-5907, option 3.

 

Interface Updates

For a complete list of interface-related test changes, click here for a downloadable document to view the impacted interface test codes.